Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.

Morgan CJA, Freeman TP, Hindocha C, Schafer G, Gardner C, Curran HV.

Transl Psychiatry. 2018 Sep 5;8(1):181. doi: 10.1038/s41398-018-0191-x.

2.

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?

Curran HV, Hindocha C, Morgan CJA, Shaban N, Das RK, Freeman TP.

Psychol Med. 2018 Sep 4:1-7. doi: 10.1017/S003329171800226X. [Epub ahead of print]

PMID:
30176957
3.

Episodic foresight deficits in regular, but not recreational, cannabis users.

Mercuri K, Terrett G, Henry JD, Curran HV, Elliott M, Rendell PG.

J Psychopharmacol. 2018 Aug;32(8):876-882. doi: 10.1177/0269881118776672. Epub 2018 Jun 13.

PMID:
29897004
4.

The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers.

Hindocha C, Freeman TP, Grabski M, Crudgington H, Davies AC, Stroud JB, Das RK, Lawn W, Morgan CJA, Curran HV.

Sci Rep. 2018 May 15;8(1):7568. doi: 10.1038/s41598-018-25846-2.

5.

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.

Hindocha C, Freeman TP, Grabski M, Stroud JB, Crudgington H, Davies AC, Das RK, Lawn W, Morgan CJA, Curran HV.

Addiction. 2018 May 1. doi: 10.1111/add.14243. [Epub ahead of print]

6.

Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability.

Braidwood R, Mansell S, Waldron J, Rendell PG, Kamboj SK, Curran HV.

Front Psychiatry. 2018 Mar 27;9:97. doi: 10.3389/fpsyt.2018.00097. eCollection 2018.

7.

Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation.

Curran HV, Nutt D, de Wit H.

Psychopharmacology (Berl). 2018 Feb;235(2):373-375. doi: 10.1007/s00213-017-4822-3. No abstract available.

PMID:
29445838
8.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.

Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8.

9.

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.

Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL.

Psychopharmacology (Berl). 2018 Feb;235(2):459-466. doi: 10.1007/s00213-017-4754-y. Epub 2017 Oct 30.

10.

Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration.

Hindocha C, Freeman TP, Curran HV.

Cannabis Cannabinoid Res. 2017 Aug 1;2(1):217-223. doi: 10.1089/can.2017.0024. eCollection 2017.

11.

The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers.

Lawn W, Freeman TP, East K, Gaule A, Aston ER, Bloomfield MAP, Das RK, Morgan CJA, Curran HV.

Nicotine Tob Res. 2018 Jun 7;20(7):800-809. doi: 10.1093/ntr/ntx159.

12.

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.

Sci Rep. 2017 Oct 13;7(1):13187. doi: 10.1038/s41598-017-13282-7.

13.

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion.

Freeman TP, Pope RA, Wall MB, Bisby JA, Luijten M, Hindocha C, Mokrysz C, Lawn W, Moss A, Bloomfield MAP, Morgan CJA, Nutt DJ, Curran HV.

Int J Neuropsychopharmacol. 2018 Jan 1;21(1):21-32. doi: 10.1093/ijnp/pyx082.

14.

Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.

Hindocha C, Lawn W, Freeman TP, Curran HV.

Psychopharmacology (Berl). 2017 Nov;234(21):3153-3163. doi: 10.1007/s00213-017-4698-2. Epub 2017 Jul 22.

15.

Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.

Hindocha C, Freeman TP, Xia JX, Shaban NDC, Curran HV.

Psychol Med. 2017 Nov;47(15):2708-2719. doi: 10.1017/S0033291717001222. Epub 2017 May 31.

16.

Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males.

Mokrysz C, Freeman TP, Korkki S, Griffiths K, Curran HV.

Transl Psychiatry. 2016 Nov 29;6(11):e961. doi: 10.1038/tp.2016.225.

17.

Processing of Alcohol-Related Health Threat in At-Risk Drinkers: An Online Study of Gender-Related Self-Affirmation Effects.

Kamboj SK, Place H, Barton JA, Linke S, Curran HV, Harris PR.

Alcohol Alcohol. 2016 Nov;51(6):756-762. Epub 2016 Mar 18.

PMID:
26993737
18.

Salience attribution and its relationship to cannabis-induced psychotic symptoms.

Bloomfield MA, Mouchlianitis E, Morgan CJ, Freeman TP, Curran HV, Roiser JP, Howes OD.

Psychol Med. 2016 Dec;46(16):3383-3395. Epub 2016 Sep 15.

19.

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.

Lawn W, Freeman TP, Pope RA, Joye A, Harvey L, Hindocha C, Mokrysz C, Moss A, Wall MB, Bloomfield MA, Das RK, Morgan CJ, Nutt DJ, Curran HV.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3537-52. doi: 10.1007/s00213-016-4383-x. Epub 2016 Sep 2.

20.

Bringing together pharmacological and psychological approaches to mental health research.

Moss A, Curran HV, Bloomfield MA, Kamboj SK, Blackwell SE, Freeman TP.

Lancet Psychiatry. 2016 Aug;3(8):700-2. doi: 10.1016/S2215-0366(16)30080-3. No abstract available.

PMID:
27475758
21.

Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysis.

Grabski M, Curran HV, Nutt DJ, Husbands SM, Freeman TP, Fluharty M, Munafò MR.

Addiction. 2016 Dec;111(12):2134-2144. doi: 10.1111/add.13507. Epub 2016 Aug 8. Review.

22.

A Moderate Dose of Alcohol Does Not Influence Experience of Social Ostracism in Hazardous Drinkers.

Buckingham J, Moss A, Gyure K, Ralph N, Hindocha C, Lawn W, Curran HV, Freeman TP.

Front Psychol. 2016 Apr 20;7:555. doi: 10.3389/fpsyg.2016.00555. eCollection 2016.

23.

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8. doi: 10.1073/pnas.1518377113. Epub 2016 Apr 11.

24.

Keep off the grass? Cannabis, cognition and addiction.

Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH.

Nat Rev Neurosci. 2016 May;17(5):293-306. doi: 10.1038/nrn.2016.28. Epub 2016 Apr 7. Review.

PMID:
27052382
25.

E-cigarettes are less harmful than smoking.

Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D.

Lancet. 2016 Mar 19;387(10024):1160-2. doi: 10.1016/S0140-6736(15)00253-6. No abstract available.

PMID:
27025332
26.

Deconstructing the nature of episodic foresight deficits associated with chronic opiate use.

Mercuri K, Terrett G, Bailey PE, Henry JD, Curran HV, Rendell PG.

Br J Clin Psychol. 2016 Nov;55(4):401-413. doi: 10.1111/bjc.12110. Epub 2016 Mar 12.

PMID:
26971561
27.

Editorial: Reporting guidelines for psychopharmacology.

Steckler T, Curran HV, de Wit H, Howes O, Hoyer D, Lucki I, Miczek KA, Morrow AL, Price LH, Robbins TW.

Psychopharmacology (Berl). 2016 Apr;233(7):1131-4. doi: 10.1007/s00213-016-4252-7. No abstract available.

PMID:
26915651
28.

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.

Morgan CJ, Freeman TP, Powell J, Curran HV.

Transl Psychiatry. 2016 Feb 16;6:e738. doi: 10.1038/tp.2015.219.

29.

Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review.

Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R.

JAMA Psychiatry. 2016 Mar;73(3):292-7. doi: 10.1001/jamapsychiatry.2015.3278. Review.

PMID:
26842658
30.

Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study.

Mokrysz C, Landy R, Gage SH, Munafò MR, Roiser JP, Curran HV.

J Psychopharmacol. 2016 Feb;30(2):159-68. doi: 10.1177/0269881115622241. Epub 2016 Jan 6.

31.

Prospective memory impairments in heavy social drinkers are partially overcome by future event simulation.

Platt B, Kamboj SK, Italiano T, Rendell PG, Curran HV.

Psychopharmacology (Berl). 2016 Feb;233(3):499-506. doi: 10.1007/s00213-015-4145-1. Epub 2015 Nov 27.

32.

Rethinking dose-response effects of cannabis use in adolescence.

Freeman TP, Mokrysz C, Curran HV.

Lancet Psychiatry. 2014 Nov;1(6):416. doi: 10.1016/S2215-0366(14)00005-4. Epub 2014 Nov 5. No abstract available.

PMID:
26361186
33.

LSD enhances the emotional response to music.

Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL.

Psychopharmacology (Berl). 2015 Oct;232(19):3607-14. doi: 10.1007/s00213-015-4014-y. Epub 2015 Aug 11.

34.

Assessing the translational feasibility of pharmacological drug memory reconsolidation blockade with memantine in quitting smokers.

Das RK, Hindocha C, Freeman TP, Lazzarino AI, Curran HV, Kamboj SK.

Psychopharmacology (Berl). 2015 Sep;232(18):3363-74. doi: 10.1007/s00213-015-3990-2. Epub 2015 Jun 21.

35.

Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.

Kamboj SK, Kilford EJ, Minchin S, Moss A, Lawn W, Das RK, Falconer CJ, Gilbert P, Curran HV, Freeman TP.

J Psychopharmacol. 2015 Sep;29(9):961-70. doi: 10.1177/0269881115587143. Epub 2015 May 18.

PMID:
25990558
36.

A specific association between facial disgust recognition and estradiol levels in naturally cycling women.

Kamboj SK, Krol KM, Curran HV.

PLoS One. 2015 Apr 15;10(4):e0122311. doi: 10.1371/journal.pone.0122311. eCollection 2015.

37.

Attentional bias and treatment adherence in substitute-prescribed opiate users.

Charles M, Wellington CE, Mokrysz C, Freeman TP, O'Ryan D, Curran HV.

Addict Behav. 2015 Jul;46:100-5. doi: 10.1016/j.addbeh.2015.03.017. Epub 2015 Mar 24.

PMID:
25838001
38.

The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards.

Lawn W, Freeman TP, Hindocha C, Mokrysz C, Das RK, Morgan CJ, Curran HV.

Psychopharmacology (Berl). 2015 Jul;232(14):2503-17. doi: 10.1007/s00213-015-3883-4. Epub 2015 Mar 12.

PMID:
25757672
39.

Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom.

Hindocha C, Shaban ND, Freeman TP, Das RK, Gale G, Schafer G, Falconer CJ, Morgan CJ, Curran HV.

Drug Alcohol Depend. 2015 Mar 1;148:165-71. doi: 10.1016/j.drugalcdep.2015.01.004. Epub 2015 Jan 13.

40.

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.

Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ, Curran HV.

Eur Neuropsychopharmacol. 2015 Mar;25(3):325-34. doi: 10.1016/j.euroneuro.2014.11.014. Epub 2014 Dec 5.

41.

Breastfeeding experience differentially impacts recognition of happiness and anger in mothers.

Krol KM, Kamboj SK, Curran HV, Grossmann T.

Sci Rep. 2014 Nov 12;4:7006. doi: 10.1038/srep07006.

42.

Episodic foresight deficits in long-term opiate users.

Mercuri K, Terrett G, Henry JD, Bailey PE, Curran HV, Rendell PG.

Psychopharmacology (Berl). 2015 Apr;232(7):1337-45. doi: 10.1007/s00213-014-3772-2. Epub 2014 Oct 17.

PMID:
25323626
43.

Effects of ecstasy on cooperative behaviour and perception of trustworthiness: a naturalistic study.

Stewart LH, Ferguson B, Morgan CJ, Swaboda N, Jones L, Fenton R, Wall MB, Curran HV.

J Psychopharmacol. 2014 Nov;28(11):1001-8. doi: 10.1177/0269881114544775. Epub 2014 Aug 13.

PMID:
25122044
44.

Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

Freeman TP, Morgan CJ, Hindocha C, Schafer G, Das RK, Curran HV.

Addiction. 2014 Oct;109(10):1686-94. doi: 10.1111/add.12634. Epub 2014 Jul 16.

PMID:
24894801
45.

Estimating the harms of nicotine-containing products using the MCDA approach.

Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D.

Eur Addict Res. 2014;20(5):218-25. doi: 10.1159/000360220. Epub 2014 Apr 3.

46.

Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.

Kamboj SK, Conroy L, Tookman A, Carroll E, Jones L, Curran HV.

Eur J Pain. 2014 Nov;18(10):1376-84. doi: 10.1002/j.1532-2149.2014.498.x. Epub 2014 Apr 3.

PMID:
24700581
47.

The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.

Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD.

Psychopharmacology (Berl). 2014 Jun;231(11):2251-9. doi: 10.1007/s00213-014-3523-4. Epub 2014 Apr 3.

PMID:
24696078
48.

Emotional processing deficits in chronic cannabis use: a replication and extension.

Hindocha C, Wollenberg O, Carter Leno V, Alvarez BO, Curran HV, Freeman TP.

J Psychopharmacol. 2014 May;28(5):466-71. doi: 10.1177/0269881114527359. Epub 2014 Mar 19.

PMID:
24646810
49.

Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward.

Freeman TP, Das RK, Kamboj SK, Curran HV.

Soc Cogn Affect Neurosci. 2015 Jan;10(1):85-92. doi: 10.1093/scan/nsu026. Epub 2014 Feb 12.

50.

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.

Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Biol Psychiatry. 2015 Oct 15;78(8):554-62. doi: 10.1016/j.biopsych.2013.12.015. Epub 2014 Jan 10.

Supplemental Content

Loading ...
Support Center